Oleanolic acid and related triterpenoids from olives on vascular function: Molecular mechanisms and therapeutic perspectives

Current Medicinal Chemistry

Volumn 22, Issue 11, 2015, Pages 1414-1425

  Rodriguez Rodriguez, Rosalia ^a,b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

Cardiovascular diseases; Oleanolic acid; Pentacyclic triterpenoids from olives; Vascular function

Indexed keywords

OLEANOLIC ACID DERIVATIVE; OLIVE OIL; TRITERPENOID; OLEANOLIC ACID; TRITERPENE;

ARTICLE; ATHEROSCLEROSIS; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; NONHUMAN; OBESITY; OLIVE; ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; CONFORMATION; OLIVE TREE; PATHOPHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MOLECULAR CONFORMATION; OLEA; OLEANOLIC ACID; TRITERPENES;

EID: 84950250789     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666141212122921     Document Type: Article

References (107)

1. World Health Organization. Cardiovascular diseases (CVDs). Fact sheet No. 317, 2013. http://www.Who.Int/cardiovasculardiseases/en/.
2. Vazzana, N.; Santilli, F.; Sestili, S.; Cuccurullo, C.; Davi, G. Determinants of increased cardiovascular disease in obesity and metabolic syndrome. Curr. Med. Chem., 2011, 18, 5267-5280.
3. Bonetti, P.O.; Lerman, L.O.; Lerman, A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 168-175.
4. Widlansky, M.E.; Gokce, N.; Keaney, J.F.; Vita, J.A. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol., 2003, 42, 1149-1160.
5. Lerman, A.; Burnett, J.C. Jr. Intact and altered endothelium in regulation of vasomotion. Circulation, 1992, 86, III-12-II-19.
6. Feletou, M.; Vanhoutte, P.M. Endothelial dysfunction: A multifaceted disorder. Am. J. Physiol. Heart Circ. Physiol., 2006, 291, H985-H1002.
7. Deanfield, J.E.; Halcox, J.P.; Rabelink, T.J. Endothelial function and dysfunction: Testing and clinical relevance. Circulation, 2007, 115, 1285-1295.
8. Ordovas, J.M. Genetic interactions with diet influence the risk of cardiovascular disease. Am. J. Clin. Nutr., 2006, 83 (2), 443S-446S.
9. Joshipura, K.J.; Hu, F.B.; Manson, J.E.; Stampfer, M.J.; Rimm, E.B.; Speizer, F.E.; Colditz, G.; Ascherio, A.; Rosner, B.; Spiegelman, D.; Willett, W.C. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann. Intern. Med., 2001, 134, 1106- 1114.
10. Hu, F.B.; Cho, E.; Rexrode, K.M.; Albert, C.M.; Manson, J.E. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation, 2003, 107, 1852-1857.
11. Togo, P.; Osler, M.; Sorensen, T.I.; Heitmann, B.L. Food intake patterns and body mass index in observational studies. Int. J. Obes. Relat. Metab. Disord., 2001, 25, 1741-1751.
12. Kant, A.K. Dietary patterns: biomarkers and chronic disease risk. Appl. Physiol. Nutr. Metab., 2010, 35, 199-206.
13. Estruch, R.; Ros, E.; Salas-Salvadó, J. The PREDIMED Study Investigators. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N. Engl. J. Med., 2013, 368, 1279-1290.
14. Martinez-Gonzalez, M.A.; Bes-Rastrollo, M.; Serra-Majem, L.; Lairon, D.; Estruch, R.; Trichopoulou, A. Mediterranean food pattern and the primary prevention of chronic disease: recent developments. Nutr. Rev., 2009, 67, S111-S116.
15. Covas, M.I.; Konstantinidou, V.; Fitó, M. Olive oil and cardiovascular health. J. Cardiovasc. Pharmacol., 2009, 54, 477-482.
16. Covas, M.I.; Ruiz-Gutiérrez, V.; De La Torre, R. Minor Components of Olive Oil: Evidence to Date of Health Benefits in Humans. Nutr. Rev., 2006, 64, 20-30.
17. Herrera, M.D.; Rodríguez-Rodríguez, R.; Ruiz-Gutiérrez, V. Functional properties of pentacyclic triterpenes contained in "orujo" olive oil. Curr. Nutr. Food Sci., 2006, 2, 45-50.
18. Lou-Bonafonte, J.M.; Arnal, C.; Navarro, M.A.; Osada, J. Efficacy of bioactive compounds from extra virgin olive oil to modulate atherosclerosis development. Mol. Nutr. Food Res., 2012, 56, 1043- 1057.
19. Sánchez-Quesada, C.; López-Biedma, A.; Warleta, F.; Campos, M.; Beltrán, G.; Gaforio, J.J. Bioactive properties of the main triterpenes found in olives, virgin olive oil, and leaves of Olea europaea. J. Agric. Food Chem., 2013, 61 (50), 12173-12182.
20. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; The, P.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 2009, 6, e1000097.
21. Hill, R.A.; Connolly, J.D. Triterpenoids. Nat. Prod. Rep., 2013, 30 (7), 1028-1065.
22. Dzubak, P.; Hajduch, M.; Vydra, D.; Hustova, A.; Kvasnica, M.; Biedermann, D.; Markova, L.; Urban, M.; Sarek, J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep., 2006, 23 (3), 394-411.
23. Osbourn, A.; Goss, R.J.; Field, R.A. The saponins: polar isoprenoids with important and diverse biological activities. Nat. Prod. Rep., 2011, 28 (7), 1261-1268.
24. Yadav, V.R.; Prasad, S.; Sung, B.; Kannappan, R.; Aggarwal, B.B. Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins (Basel), 2010, 2 (10), 2428-2466.
25. Ríos, J.L. Effects of triterpenes on the immune system. J. Ethnopharmacol., 2010, 128 (1), 1-14.
26. Allouche, Y.; Uceda, M.; Jiménez, A.; Aguilera, M.P.; Gaforio, J.J.; Beltrán, G. Fruit quality and olive leaf and stone addition affect Picual virgin olive oil triterpenic content. J. Agric. Food Chem., 2009, 57, 8998-9001.
27. Pérez-Camino, M.C.; Cert, A. Quantitative determination of hydroxy pentacyclic triterpene acids in vegetable oils. J. Agric. Food Chem., 1999, 47, 1558-1562.
28. Liu, J. Oleanolic acid and ursolic acid: research perspectives. J. Ethnopharmacol., 2005, 100, 92-94.
29. Simonsen, U.; Rodriguez-Rodriguez, R.; Dalsgaard, T.; Buus, N.H.; Stankevicius, E. Novel approaches to improving endotheliumdependent nitric oxide-mediated vasodilatation. Pharmacol. Rep., 2009, 61, 105-115.
30. Rodriguez-Rodriguez, R.; Ruiz-Gutierrez, V. Functional properties of pentacyclic triterpenes contained in pomace olive oil. In: Olives and olive oil in health and disease prevention. Ed. Oxford Academic Press/Elsevier, London. 2010, 1431-1438.
31. Liby, K.T.; Sporn, M.B. Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol. Rev., 2012, 64, 972- 1003.
32. Alqahtani, A.; Hamid, K.; Kam, A.; Wong, K.H.; Abdelhak, Z.; Razmovski-Naumovski, V.; Chan, K.; Li, K.M.; Groundwater, P.W.; Li, G.Q. The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Curr. Med. Chem., 2013, 20 (7), 908-931.
33. Somova, L.I.; Shode, F.O.; Ramnanan, P.; Nadar, A. Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J. Ethnopharmacol., 2003, 84, 299-305.
34. Somova, L.I.; Shode, F.O.; Mipando, M. Cardiotonic and antidysrhythmic effects of oleanolic and ursolic acids, methyl maslinate and uvaol. Phytomedicine, 2004, 11, 121-129.
35. Rodríguez-Rodríguez, R.; Herrera, M.D.; Perona, J.S.; Ruiz- Gutiérrez, V. Potential vasorelaxant effects of oleanolic acid and erythrodiol, two triterpenoids contained in 'orujo' olive oil, on rat aorta. Br. J. Nutr., 2004, 92, 635-642.
36. Rodriguez-Rodriguez, R.; Perona, J.S.; Herrera, M.D.; Ruiz- Gutierrez, V. Triterpenic compounds from "orujo" olive oil elicit vasorelaxation in aorta from spontaneously hypertensive rats. J. Agric. Food Chem., 2006, 54, 2096-2102.
37. Shimokawa, H.; Yasutake, H.; Fujii, K. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J. Cardiovasc. Pharmacol., 1996, 28, 703-711.
38. Shimokawa, H. Endothelial dysfunction in hypertension. J. Atheroscler. Thromb., 1998, 4, 118-127.
39. Marquez-Martin, A.; De La Puerta, R.; Fernandez-Arche, A.; Ruiz- Gutierrez, V.; Yaqoob, P. Modulation of cytokine secretion by pentacyclic triterpenes from olive pomace oil in human mononuclear cells. Cytokine, 2006, 36, 211-217.
40. Dongmo, A.B., Azebaze, A.G., Donfack, F.M. Pentacyclic triterpenoids and ceramide mediate the vasorelaxant activity of Vitex cienkowskii via involvement of NO/cGMP pathway in isolated rat aortic rings. J. Ethnopharmacol., 2011, 133, 204-212.
41. Aguirre-Crespo, F.; Vergara-Galicia, J.; Villalobos-Molina, R.; López-Guerrero, J.; Navarrete-Vázquez, G.; Estrada-Soto, S. Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta. Life Sci., 2006, 79, 1062-1068.
42. Rodriguez-Rodriguez, R.; Stankevicius, E.; Herrera, M.D. Oleanolic acid induces relaxation and calcium-independent release of endothelium- derived nitric oxide. Br. J. Pharmacol., 2008, 155, 535-546.
43. Prades, J., Vögler, O., Alemany, R. Plant pentacyclic triterpenic acids as modulators of lipid membrane physical properties. Biochim. Biophys. Acta., 2011, 1808, 752-760.
44. Fleming, I.; Busse, R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2003, 84, R1-12.
45. Feletou, M.; Vanhoutte, P.M. EDHF: An update. Clin. Sci. (Lond)., 2009, 11, 139-155.
46. Ruíz-Gutiérrez, V.; Muriana, F.J.; Guerrero, A.; Cert, A.M.; Villar, J. Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J. Hypertens., 1996, 14, 1483-1490.
47. Psaltopoulou, T.; Naska, A.; Orfanos, P.; Trichopoulos, D.; Mountokalakis, T.; Trichopoulou, A. Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am. J. Clin. Nutr., 2004, 80, 1012-1018.
48. Bondia-Pons, I.; Schröder, H.; Covas, M.I. Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. J. Nutr., 2007, 137, 84-87.
49. Perona, J.S.; Rodríguez-Rodríguez, R.; Ruiz-Gutierrez, V. Effects of oleic acid rich oils on aorta lipids and lipoprotein lipase activity of spontaneously hypertensive rats. J. Agric. Food Chem., 2005, 53, 7330-7336.
50. Perona, J.S.; Cabello-Moruno, R.; Ruiz-Gutierrez, V. The role of virgin olive oil components in the modulation of endothelial function. J. Nutr. Biochem., 2006, 17, 429-445.
51. Rodriguez-Rodriguez, R.; Herrera, M.D.; De Sotomayor, M.A.; Ruiz-Gutierrez, V. Pomace olive oil improves endothelial function in spontaneously hypertensive rats by increasing endothelial nitric oxide synthase expression. Am. J. Hypertens., 2007, 20, 728-734.
52. Rodriguez-Rodriguez, R.; Herrera, M.D.; De Sotomayor, M.A.; Ruiz-Gutierrez, V. Effects of pomace olive oil-enriched diets on endothelial function of small mesenteric arteries from spontaneously hypertensive rats. Br. J. Nutr., 2009, 102, 1435-1444.
53. Valero-Muñoz, M.; Martín-Fernández, B.; Ballesteros, S.; De la Fuente, E.; Quintela, J.C.; Lahera, V.; De las Heras, N. Protective effect of a pomace olive oil concentrated in triterpenic acids in alterations related to hypertension in rats: mechanisms involved. Mol. Nutr. Food Res., 2014, 58 (2), 376-383.
54. Hossain, P.; Kawar, B.; El Nahas, M. Obesity and diabetes in the developing world-a growing challenge. N. Engl. J. Med., 2007, 356 (3), 213-215.
55. Mitjavila, M.T.; Fandos, M.; Salas-Salvadó, J.; Covas, M.I.; Borrego, S.; Estruch, R.; Lamuela-Raventós, R.; Corella, D.; Martínez- Gonzalez, M.Á.; Sánchez, J.M.; Bulló, M.; Fitó, M.; Tormos, C.; Cerdá, C.; Casillas, R.; Moreno, J.J.; Iradi, A.; Zaragoza, C.; Chaves, J.; Sáez, G.T. The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial. Clin. Nutr., 2013, 32 (2), 172-178.
56. El, S.N.; Karakaya, S. Olive tree (Olea europaea) leaves: potential beneficial effects on human health. Nutr. Rev., 2009, 67 (11), 632- 638.
57. Eidi, A.; Eidi, M.; Darzi, R. Antidiabetic effect of Olea europaea L. in normal and diabetic rats. Phytother. Res., 2009, 23 (3), 347-350.
58. Wainstein, J.; Ganz, T.; Boaz, M.; Bar Dayan, Y.; Dolev, E.; Kerem, Z.; Madar, Z., Olive Leaf Extract as a Hypoglycemic Agent in Both Human Diabetic Subjects and in Rats. J. Med. Food., 2012, 15 (7), 605-610.
59. Kaeidi, A.; Esmaeili-Mahani, S.; Sheibani, V.; Abbasnejad, M.; Rasoulian, B.; Hajializadeh, Z.; Afrazi, S., Olive (Olea europaea L.) leaf extract attenuates early diabetic neuropathic pain through prevention of high glucose-induced apoptosis: in vitro and in vivo studies. J. Ethnopharmacol., 2011, 136 (1), 188-196.
60. Pérez-Martínez, P.; García-Ríos, A.; Delgado-Lista, J.; Pérez- Jiménez, F.; López-Miranda, J. Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr. Pharm. Des., 2011, 17 (8), 769-777.
61. Salas-Salvadó, J.; Martinez-González, M.Á.; Bulló, M.; Ros, E. The role of diet in the prevention of type 2 diabetes. Nutr. Metab. Cardiovasc. Dis., 2011, 21 Suppl 2, B32-B48.
62. Schröder, H. Protective mechanisms of the Mediterranean diet in obesity and type 2 diabetes. J. Nutr. Biochem., 2007, 18 (3), 149- 160.
63. Sheng, H.; Sun, H. Synthesis, biology and clinical significance of pentacyclic triterpenes: A multi-target approach to prevention and treatment of metabolic and vascular diseases. Nat. Prod. Rep., 2011, 28 (3), 543-593.
64. Castellano, J.M.; Guinda, A.; Delgado, T.; Rada, M.; Cayuela, J.A. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes, 2013, 62 (6), 1791-1799.
65. Ortiz-Andrade, R.R.; García-Jiménez, S.; Castillo-España, P.; Ramírez-Avila, G.; Villalobos-Molina, R.; Estrada-Soto, S. Alpha- Glucosidase inhibitory activity of the methanolic extract from Tournefortia hartwegiana: An anti-hyperglycemic agent. J. Ethnopharmacol., 2007, 109 (1), 48-53.
66. Hou, W.; Li, Y.; Zhang, Q.; Wei, X.; Peng, A.; Chen, L.; Wei, Y. Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha- glucosidase inhibitors. Phytother. Res., 2009, 23 (5), 614-618.
67. Komaki, E.; Yamaguchi, S.; Maru, I.; Kinoshita, M.; Karehi, K.; Ohta, Y.; Tsukada, Y. Identification of anti-alpha-amylase components from olive leaf extracts. Food Sci. Tech. Res., 2003, 9 (1), 35- 39.
68. Gilon, P.; Henquin, J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr. Rev., 2001, 22 (5), 565-604.
69. Hsu, J.H.; Wu, Y.C.; Liu, I.M.; Cheng, J.T. Release of acetylcholine to raise insulin secretion in Wistar rats by oleanolic acid, one of the active principles contained in Cornus officinalis. Neurosci. Lett., 2006, 404 (1-2), 112-116.
70. Nataraju, A.; Saini, D.; Ramachandran, S.; Benshoff, N.; Liu, W.; Chapman, W.; Mohanakumar, T. Oleanolic Acid, a plant triterpenoid, significantly improves survival and function of islet allograft. Transplantation, 2009, 88 (8), 987-994.
71. Bu, Y.; Shi, T.; Meng, M.; Kong, G.; Tian, Y.; Chen, Q.; Yao, X.; Feng, G.; Chen, H.; Lu, Z. A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2. Bioorg. Med. Chem. Lett., 2011, 21 (2), 874-878.
72. Teodoro, T.; Zhang, L.; Alexander, T.; Yue, J.; Vranic, M.; Volchuk, A. Oleanolic acid enhances insulin secretion in pancreatic beta-cells. FEBS Lett., 2008, 582 (9), 1375-1380.
73. Sato, H.; Genet, C.; Strehle, A.; Thomas, C.; Lobstein, A.; Wagner, A.; Mioskowski, C.; Auwerx, J.; Saladin, R. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem. Biophys. Res. Commun., 2007, 362 (4), 793-798.
74. Ramírez-Espinosa, J.J.; Rios, M.Y.; López-Martínez, S.; López- Vallejo, F.; Medina-Franco, J.L.; Paoli, P.; Camici, G.; Navarrete- Vázquez, G.; Ortiz-Andrade, R.; Estrada-Soto, S. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches. Eur. J. Med. Chem., 2011, 46 (6), 2243-2251.
75. Zhang, Y.N.; Zhang, W.; Hong, D.; Shi, L.; Shen, Q; Li, J.Y.; Li, J.; Hu, L.H. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorg. Med. Chem., 2008, 16 (18), 8697-8705.
76. Qiu, W.W.; Shen, Q.; Yang, F.; Wang, B.; Zou, H.; Li, J.Y.; Li, J.; Tang, J. Synthesis and biological evaluation of heterocyclic ringsubstituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. Bioorg. Med. Chem. Lett., 2009, 19 (23), 6618-6622.
77. Wang, X.; Li, Y.L.; Wu, H.; Liu, J.Z.; Hu, J.X.; Liao, N.; Peng, J.; Cao, P.P.; Liang, X.; Hai, C.X. Antidiabetic effect of oleanolic acid: A promising use of a traditional pharmacological agent. Phytother. Res., 2011, 25, 1031-1040.
78. Mapanga, R.F.; Rajamani, U.; Dlamini, N.; Zungu-Edmondson, M.; Kelly-Laubscher, R.; Shafiullah, M.; Wahab, A.; Hasan, M.Y.; Fahim, M.A.; Rondeau, P.; Bourdon, E.; Essop, M.F. Oleanolic acid: A novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. PLoS One, 2012, 7, e47322.
79. Huang, T.H.; Yang, Q.; Harada, M.; Li, G.Q.; Yamahara, J.; Roufogalis, B.D.; Li, Y. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. J. Cardiovasc. Pharmacol., 2005, 46 (6), 856-862.
80. Kuroda, M.; Mimaki, Y.; Ohtomo, T.; Yamada, J.; Nishiyama, T.; Mae, T.; Kishida, H.; Kawada, T. Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-Ay mice and identification of the active ingredients. J. Nat. Med., 2012, 66 (2), 394-399.
81. Sung, H.Y.; Kang, S.W.; Kim, J.L.; Li, J.; Lee, E.S.; Gong, J.H.; Han, S.J.; Kang, Y.H. Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes. Nutr. Res., 2010, 30, 831-839.
82. Kim, H.S.; Sung, H.Y.; Kim, M.S.; Kim, J.L.; Kang, M.K.; Gong, J.H.; Park, H.S.; Kang, Y.H. Oleanolic acid suppresses resistin induction in adipocytes by modulating Tyk-STAT signaling. Nutr. Res., 2013, 33, 144-153.
83. Feng, J.; Zhang, P.; Chen, X.; He, G. PI3K and ERK/Nrf2 pathways are involved in oleanolic acid-induced heme oxygenase-1 expression in rat vascular smooth muscle cells. J. Cell. Biochem., 2011, 112, 1524-1531.
84. Libby, P.; Ridker, P.M.; Hansson, G.K. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011, 473, 317- 325.
85. Allouche, Y.; Beltrán, G.; Gaforio, J.J.; Uceda, M.; Mesa, M.D. Antioxidant and antiatherogenic activities of pentacyclic triterpenic diols and acids. Food Chem. Toxicol., 2010, 48, 2885-2890.
86. Marquez-Martin A, de la Puerta-Vazquez R, Fernandez-Arche A, Ruiz-Gutierrez V. Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages. Free Radic Res. 2006, 40, 295-302.
87. Balanehru, S.; Nagarajan, B. Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem. Int., 1991, 24, 981- 990.
88. Rong, Z.T.; Gong, X.J.; Sun, H.B.; Li, Y.M.; Ji, H. Protective effects of oleanolic acid on cerebral ischemic damage in vivo and H(2)O(2)-induced injury in vitro. Pharm. Biol., 2011, 49, 78-85.
89. Wang, X.; Ye, X.L.; Liu, R. Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem. Biol. Interact., 2010, 184, 328-337.
90. Graham, V.S.; Lawson, C.; Wheeler-Jones, C.P.; Perona, J.S.; Ruiz-Gutierrez, V.; Botham, K.M. Triacylglycerol-rich lipoproteins derived from healthy donors fed different olive oils modulate cytokine secretion and cyclooxygenase-2 expression in macrophages: The potential role of oleanolic acid. Eur. J. Nutr., 2012, 51, 301-309.
91. Martínez-González, J.; Rodríguez-Rodríguez, R.; González-Díez, M. Oleanolic acid induces prostacyclin release in human vascular smooth muscle cells through a cyclooxygenase-2-dependent mechanism. J. Nutr., 2008, 138, 443-448.
92. Takada, K.; Nakane, T.; Masuda, K.; Ishii, H. Ursolic acid and oleanolic acid, members of pentacyclic triterpenoid acids, suppress TNF-α-induced E-selectin expression by cultured umbilical vein endothelial cells. Phytomedicine, 2010, 17, 1114-1119.
93. Buus, N.H.; Hansson, N.C.; Rodriguez-Rodriguez, R.; Stankevicius, E.; Andersen, M.R.; Simonsen, U. Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice. Eur. J. Pharmacol., 2011, 670, 519-526.
94. Liu, J.; Sun, H.; Shang, J.; Yong, Y.; Zhang, L. Effect of olive pomace extracts on hyperlipidaemia. Nat. Prod. Res., 2011, 25, 1190- 1194.
95. Yin, M.C.; Lin, M.C.; Mong, M.C.; Lin, C.Y. Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice. J. Agric. Food Chem., 2012, 60, 7697-7701.
96. Chen, M.; Zhong, Z.; Tan, W.; Wang, S.; Wang, Y. Recent advances in nanoparticle formulation of oleanolic acid. Chin. Med., 2011, 6 (1), 20.
97. Song, M.; Hang, T.J.; Wang, Y. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J. Pharm. Biomed. Anal., 2006, 40, 190-196.
98. Rada, M.; Ruiz-Gutiérrez, V.; Guinda, Á. Determination of triterpenic acids in human serum by high-performance liquid chromatography: Triterpenoid interaction with serum protein. J. Agric. Food Chem., 2011, 59, 2308-2313.
99. Sánchez-González, M.; Colom, H.; Lozano-Mena, G.; Juan, M.E.; Planas, J.M. Population pharmacokinetics of maslinic acid, a triterpene from olives, after intravenous and oral administration in rats. Mol. Nutr. Food Res., 2014, 58 (10), 1970-1979.
100. Lozano-Mena, G.; Juan, M.E.; García-Granados, A.; Planas, J.M. Determination of maslinic acid, a pentacyclic triterpene from olives, in rat plasma by high-performance liquid chromatography. J. Agric. Food Chem., 2012, 60 (41), 10220-5.
101. Xi, J.; Chang, Q.; Chan, C.K. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS Pharm. Sci. Tech., 2009, 10, 172- 182.
102. Yang, R.; Huang, X.; Dou, J.; Zhai, G.; Su, L. Selfmicroemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation. Int. J. Nanomedicine, 2013, 8, 2917-26.
103. Gao, D.; Tang, S.; Tong, Q. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery. Int. J. Nanomedicine, 2012, 7, 3517-3526.
104. Cao, F.; Gao, Y.; Wang, M.; Fang, L.; Ping, Q. Propylene glycollinked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics. Mol. Pharm., 2013, 10 (4), 1378-87.
105. Li, W.; Das, S.; Ng, K.Y.; Heng, P.W. Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic Acid. Pharm. Res., 2011, 28, 2020-2033.
106. Li, W.; Ng, K.Y.; Heng, P.W. Development and evaluation of optimized sucrose ester stabilized oleanolic acid nanosuspensions prepared by wet ball milling with design of experiments. Biol. Pharm. Bull., 2014, 37 (6), 926-37.
107. Tesauro, M.; Cardillo, C. Obesity, blood vessels and metabolic syndrome. Acta. Physiol. (Oxf)., 2011, 203, 279-286.